Funding

Assessment and Medication from 2026

The way ADHD assessments and medication are done is changing in 2026. We encourage people to make informed decisions in an evolving field.

Please see information below. Correct as of July 2025.

What’s Changing – Adults

From February 2026, General Practitioners (GPs) and Nurse Practitioners will be able to diagnose and start medical treatment for adults with ADHD, following decisions by Medsafe and Pharmac.

Our Role as a Private Provider

Continue to deliver gold-standard, comprehensive diagnostic assessments and treatment options for ADHD, AuDHD, and ASD, including medication consultations, titration packages, neurodiversity-affirming talk therapy, and coaching.
We’re connecting with GPs and Nurse Practitioners to support them as they transition into this expanded role.

What You Can Do

Check with your GP or Nurse Practitioner: Ask whether they will be training to diagnose and prescribe ADHD medications from 1 February 2026. Not all GPs will be providing this service.
Stay informed:
- Ministry of Health – New Zealand
- Pharmac – Decision to change regulatory and funding restrictions for ADHD stimulant medicines

Funding support

The following links are organizations that you can contact to explore funding options. It is important to keep in mind that many of these services have specific criteria for providing funding, so they may not all be suitable for you.